Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.660
AS - Asia 16.961
EU - Europa 10.164
SA - Sud America 1.734
Continente sconosciuto - Info sul continente non disponibili 1.439
AF - Africa 317
OC - Oceania 76
Totale 54.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.429
VN - Vietnam 4.960
SG - Singapore 4.881
IT - Italia 2.949
CN - Cina 2.916
HK - Hong Kong 1.569
RU - Federazione Russa 1.410
DE - Germania 1.392
BR - Brasile 1.258
CA - Canada 959
SE - Svezia 948
IE - Irlanda 700
GB - Regno Unito 579
UA - Ucraina 516
IN - India 479
FR - Francia 457
KR - Corea 394
BD - Bangladesh 356
ID - Indonesia 254
FI - Finlandia 241
JP - Giappone 183
TR - Turchia 183
AR - Argentina 173
AT - Austria 160
NL - Olanda 156
IQ - Iraq 127
MX - Messico 118
ES - Italia 115
ZA - Sudafrica 108
PL - Polonia 97
LT - Lituania 88
DK - Danimarca 87
PK - Pakistan 87
CH - Svizzera 72
CO - Colombia 72
BE - Belgio 68
PH - Filippine 64
SA - Arabia Saudita 64
EC - Ecuador 63
VE - Venezuela 62
AU - Australia 59
IR - Iran 53
TW - Taiwan 52
EG - Egitto 41
MY - Malesia 38
UZ - Uzbekistan 35
MA - Marocco 31
PY - Paraguay 30
TH - Thailandia 30
TN - Tunisia 30
CL - Cile 29
AE - Emirati Arabi Uniti 27
JO - Giordania 27
KE - Kenya 27
ET - Etiopia 25
JM - Giamaica 25
KZ - Kazakistan 25
IL - Israele 24
NP - Nepal 23
CR - Costa Rica 22
RO - Romania 20
OM - Oman 19
EU - Europa 18
HN - Honduras 17
AZ - Azerbaigian 16
BG - Bulgaria 16
NZ - Nuova Zelanda 16
PE - Perù 16
BO - Bolivia 14
CZ - Repubblica Ceca 14
NI - Nicaragua 14
PS - Palestinian Territory 14
UY - Uruguay 14
PA - Panama 13
GR - Grecia 11
AL - Albania 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
BH - Bahrain 9
GT - Guatemala 8
KG - Kirghizistan 8
PR - Porto Rico 8
RS - Serbia 8
NG - Nigeria 7
NO - Norvegia 7
AO - Angola 6
BB - Barbados 6
MD - Moldavia 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
EE - Estonia 5
LB - Libano 5
SK - Slovacchia (Repubblica Slovacca) 5
BZ - Belize 4
HU - Ungheria 4
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
Totale 52.849
Salva come PNG Salva come JPEG
Città #
Singapore 3.046
Ann Arbor 2.832
Ashburn 2.248
Dallas 1.815
San Jose 1.792
Ho Chi Minh City 1.545
Hong Kong 1.473
Hanoi 1.192
Milan 1.095
Frankfurt am Main 701
Dublin 677
Woodbridge 650
Chandler 649
Toronto 608
Council Bluffs 593
New York 550
Wilmington 544
Los Angeles 531
Jacksonville 477
Houston 456
Santa Clara 454
Dearborn 453
Beijing 424
Fairfield 405
Chicago 310
Hefei 288
Boardman 286
Seoul 281
Princeton 275
The Dalles 237
Columbus 222
Rome 220
Seattle 214
Nanjing 200
Buffalo 181
Jakarta 175
Shanghai 168
Lauterbourg 153
Da Nang 136
Haiphong 136
Cambridge 127
Moscow 125
Vienna 125
São Paulo 119
Ha Long 118
Orem 110
Munich 109
Guangzhou 105
Hải Dương 104
Helsinki 100
Phoenix 98
Tokyo 98
Biên Hòa 82
Quận Bình Thạnh 81
Montreal 78
Atlanta 76
Lachine 75
London 75
Chennai 74
Denver 74
Dong Ket 74
Brooklyn 71
Lawrence 69
Nanchang 67
Thái Nguyên 67
Vilnius 67
Ninh Bình 66
Can Tho 65
Bắc Ninh 62
Altamura 61
Vũng Tàu 61
Warsaw 60
Nuremberg 58
Shenyang 56
Amsterdam 55
Zurich 53
Baghdad 51
Bắc Giang 51
Johannesburg 51
Andover 49
Stockholm 49
Jinan 47
Pune 46
Tianjin 45
Boston 44
Fremont 44
Poplar 44
Baltimore 43
Figino 43
Quận Một 43
Rio de Janeiro 43
Quận Phú Nhuận 42
San Diego 42
Turku 42
San Francisco 41
Changsha 40
Zhengzhou 40
Brussels 39
Springfield 39
Basingstoke 38
Totale 32.713
Salva come PNG Salva come JPEG
Nome #
Role of ER-mitochondria interaction in the mechanism of chemotherapy-induced peripheral neuropathy 817
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 671
CIPN and its mechanism of development 669
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 601
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 579
Bortezomib-induced peripheral neuropathy: an up-close look at endoplasmic reticulum-mitochondria interaction 550
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 531
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 528
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 525
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 516
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 493
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 485
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 475
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 473
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 458
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 451
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 438
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 438
Age-related changes in the function and structure of the peripheral sensory pathway in mice 434
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 424
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 421
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 420
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 419
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 409
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 406
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 401
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 401
Chemotherapy-induced peripheral neuropathy: a focus on mitochondria and ER- MITOCHONDRIA INTERACTIONS 399
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 394
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 392
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 387
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 380
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 377
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 377
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 373
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 373
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 372
Chemotherapy-induced peripheral neuropathy: a focus on ER-mitochondrial interactions 371
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 368
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 367
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 353
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 350
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 349
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 346
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 345
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 344
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 344
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 343
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 341
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 340
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 336
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 335
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 333
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 329
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 324
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 320
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 320
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 319
In vivo study of Carfilzomib-Induced Neuropathy 319
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 318
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 317
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 316
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 316
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 314
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 310
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 308
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 308
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 307
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 305
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 299
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 299
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 299
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 296
Multimodal experimental approach to the study of human neurological diseases 293
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 292
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 291
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 288
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 288
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 288
MSCs effect on Dark Agouti rats affected by chronic EAE 285
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 283
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 281
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 280
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 279
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 278
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 278
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 278
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 276
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 275
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 274
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 272
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 272
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 272
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 271
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 269
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 269
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 268
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 268
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 266
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 265
Totale 36.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.197
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.363 0 0 0 180 142 174 84 99 67 121 143 353
2022/20232.954 376 728 332 265 215 481 42 142 219 43 75 36
2023/20242.510 82 64 68 86 329 579 405 114 146 53 45 539
2024/20258.007 419 853 660 428 646 379 511 280 928 1.076 694 1.133
2025/202624.827 4.578 2.430 2.633 1.812 1.951 1.170 2.843 1.109 1.662 1.743 1.312 1.584
2026/20274.450 865 995 2.311 279 0 0 0 0 0 0 0 0
Totale 54.351